RIN1 (Ras and Rab interactor 1) is a multifunctional effector protein that regulates cellular signaling, adhesion, and migration through multiple mechanisms. As a Ras effector, RIN1 can compete with RAF1 for binding to activated Ras and functions as a guanine nucleotide exchange factor for RAB5A, facilitating receptor endocytosis 1. RIN1 directly binds and activates ABL tyrosine kinases through their SH3 and SH2 domains, leading to phosphorylation of CRK and CRKL proteins, which inhibits these cytoskeletal regulators and reduces epithelial cell motility and adhesion 1. PGE2-dependent phosphorylation of RIN1 at Ser291 and Ser292 blocks TGFβ-induced Ras/Raf signaling and cellular migration 2. In cancer contexts, RIN1 exhibits tissue-specific roles: it acts as a tumor suppressor in thyroid carcinoma by regulating MAPK pathway signaling 3, shows reduced expression in head and neck tumors 4, but promotes malignancy in renal cell carcinoma through EGFR signaling via Rab25 interaction 5 and correlates with poor prognosis in non-small cell lung cancer 6. These findings establish RIN1 as a critical regulator of cellular behavior with context-dependent oncogenic or tumor suppressive functions.